Videos / Weight management and cardiovascular risk reduction: The role of Semaglutide 2.4mg
Weight management and cardiovascular risk reduction: The role of Semaglutide 2.4mg
Description
In this Product Explainer, Dr. Robert Hungerford, GP with a special interest in ASCVD, heart failure and diabetes, explains the role of Semaglutide 2.4mg in weight management and cardiovascular risk reduction in secondary prevention (7 mins).
NEXT LIVE Webcast
:
Days
:
Hours
:
Minutes
Seconds
Expert panel – A/Prof Samantha Hocking & Dr Terri-Lynne South, facilitated by A/Prof Ralph Audehm
GLP 1s & Sarcopenia: Fact vs Hype
Dr Deb Mills
The New Dengue Vaccine – What You Need to Know
Dr Robert Hungerford
Hypertriglyceridaemia – Causes, Assessment & Management of CV Risk
A/Prof Michelle Rodrigues
Management of Photoageing
Join us for the next free webcast for GPs and healthcare professionals
High quality lectures delivered by leading independent experts
